favipiravir
25 Cr Pills, 50 Lakh Vials, Sales of Rs 2,800 Cr: Growth Story of India’s 2 anti-Covid Drugs
Most Drugs for Treating Adult Covid Patients Not Recommended for Kids: Govt Guidelines
Odisha Govt Orders Probe into 'Fake' Covid-19 Medicine Circulation
Glenmark Says Interim Data from Study Supports Favipiravir's Safety, Effectiveness in Covid Treatment
BMC to Shut Inoculation Centres in Mumbai Tomorrow Due to 'Vaccine Shortage'
Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
Remdesivir, Favipiravir Sales Exceeded Rs 1,000 Crore Just 7 Months After Launch in 2020: Report
SC Seeks Centre's Reply on Plea Alleging No Approval for Remdesivir, Favipiravir to Treat Covid-19
No Significant Benefit of Umifenovir in Covid-19 Treatment, Says Glenmark
Hetero Launches Pack of Generic Covid-19 Drug Favipiravir at Rs 2,640
Govt in Talks With to Russia for Possible Advancement of Covid-19 Vaccine in India: MoS Health
Covid-19 Drugs Favipiravir and Remdesivir to be Available in Stores in Odisha as Cases Continue to Mount
PIL in SC for CBI Probe for Using Two Antiviral Medicines as Treatment to Covid-19 Patients
BDR Pharma To Launch Favipiravir Tablets for Treating Covid-19 Patients at Rs 990
India's Covid-19 Fatality Rate Slides to 1.76 Percent, One of the Lowest Globally: Health Ministry
FDC Launches Two Variants of Favipiravir for Covid-19 Treatment in India at Rs 55 Per Tablet
Brinton Pharma Gets DCGI Nod to Launch Favipiravir 400 mg Tablets for Covid-19 Treatment
Dr Reddy's Launches Home Delivery of Covid-19 Treatment Drug 'Avigan' in 42 Cities
Glenmark to Launch 400 mg of Antiviral Drug FabiFlu for Covid-19 Treatment
Alkem Launches Favipiravir under Brand Name 'Alfluenza' for Covid-19 Treatment
